nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A single dose of killed Mycobacterium bovis BCG in a novel class of adjuvant (Novasome™) protects guinea pigs from lethal tuberculosis
|
Chambers, Mark A |
|
2004 |
22 |
8 |
p. 1063-1071 9 p. |
artikel |
2 |
Comparison of different routes of vaccination for eliciting antibody responses in the human stomach
|
Johansson, Eva-Liz |
|
2004 |
22 |
8 |
p. 984-990 7 p. |
artikel |
3 |
Editorial Board/Aims and Scope
|
|
|
2004 |
22 |
8 |
p. IFC- 1 p. |
artikel |
4 |
Evaluation of BBG2Na in infant macaques: specific immune responses after vaccination and RSV challenge
|
de Waal, Leon |
|
2004 |
22 |
8 |
p. 915-922 8 p. |
artikel |
5 |
Expression and characterisation of recombinant oligomeric envelope glycoproteins derived from primary isolates of HIV-1
|
Jeffs, S.A |
|
2004 |
22 |
8 |
p. 1032-1046 15 p. |
artikel |
6 |
Immune responses to a GnRH-based anti-fertility immunogen, induced by different adjuvants and subsequent effect on vaccine efficacy
|
Ferro, Valerie A. |
|
2004 |
22 |
8 |
p. 1024-1031 8 p. |
artikel |
7 |
Immunization of chimpanzees with an envelope protein-based vaccine enhances specific humoral and cellular immune responses that delay hepatitis C virus infection
|
Puig, Montserrat |
|
2004 |
22 |
8 |
p. 991-1000 10 p. |
artikel |
8 |
Intranasal immunization with genetically detoxified diphtheria toxin induces T cell responses in humans: enhancement of Th2 responses and toxin-neutralizing antibodies by formulation with chitosan
|
McNeela, Edel A |
|
2004 |
22 |
8 |
p. 909-914 6 p. |
artikel |
9 |
ISCOM® based vaccines for cancer immunotherapy
|
Lenarczyk, Aleksandra |
|
2004 |
22 |
8 |
p. 963-974 12 p. |
artikel |
10 |
Precise answers to the wrong question: prospective clinical trials and the meta-analyses of pneumococcal vaccine in elderly and high-risk adults
|
Fedson, David S |
|
2004 |
22 |
8 |
p. 927-946 20 p. |
artikel |
11 |
Prospective population-based incidence of Haemophilus influenzae type b meningitis in Thailand
|
Rerks-Ngarm, Supachai |
|
2004 |
22 |
8 |
p. 975-983 9 p. |
artikel |
12 |
Protection against plague afforded by immunisation with DNA vaccines optimised for expression of the Yersinia pestis V antigen
|
Garmory, Helen S |
|
2004 |
22 |
8 |
p. 947-957 11 p. |
artikel |
13 |
Safety and immunogenicity of a booster dose of inactivated poliovirus vaccine produced in vero-cells
|
Haastrup, Eva |
|
2004 |
22 |
8 |
p. 958-962 5 p. |
artikel |
14 |
Scientific challenges for the quality control and production of group C meningococcal conjugate vaccines
|
Jódar, Luis |
|
2004 |
22 |
8 |
p. 1047-1053 7 p. |
artikel |
15 |
Specific erythrocyte binding capacity and biological activity of Plasmodium falciparum-derived rhoptry-associated protein 1 peptides
|
Curtidor, Hernando |
|
2004 |
22 |
8 |
p. 1054-1062 9 p. |
artikel |
16 |
The role of pharmacists in the delivery of influenza vaccinations
|
Steyer, Terrence E. |
|
2004 |
22 |
8 |
p. 1001-1006 6 p. |
artikel |
17 |
Th-1/Th-2 type cytokine profiles of pig T-cells cultured with antigen-treated monocyte-derived dendritic cells
|
Raymond, Claudine R |
|
2004 |
22 |
8 |
p. 1016-1023 8 p. |
artikel |
18 |
Trypanosome microtubule-associated protein p15 as a vaccine for the prevention of African sleeping sickness
|
Rasooly, Reuven |
|
2004 |
22 |
8 |
p. 1007-1015 9 p. |
artikel |
19 |
Vaccination of infant macaques with a recombinant modified vaccinia virus Ankara expressing the respiratory syncytial virus F and G genes does not predispose for immunopathology
|
de Waal, Leon |
|
2004 |
22 |
8 |
p. 923-926 4 p. |
artikel |